• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 再感染。

COVID-19 reinfections.

出版信息

Epidemiol Mikrobiol Imunol. 2021 Spring;70(1):62-67.

PMID:33853339
Abstract

Reports of SARS-CoV-2 reinfections are on the rise. This study focused on reinfections in patients with confirmed COVID-19 in the Czech Republic. Between 1 March 2020 and 9 November 2020, 362 084 cases with the onset of symptoms before 31 October 2020 were reported. Overall, 28 cases of symptomatic SARS-CoV-2 reinfections were identified, 11 in males and 17 in females, age range 25-80 years, median age 46 years. The interval between the first and second episodes of the disease ranged from 101 to 231 days, and the median interval was 201.5 days. During both symptomatic episodes, all patients have been tested by RT-PCR. Altogether 26 patients (92.9%) have been tested negative after recovery from the first episode of COVID-19. Symptomatic reinfections occurred in nearly 0.2% of all patients at risk. Most patients with reinfection had mild symptoms in both episodes, and only three episodes were moderate to severe. Thus, reinfections may have been underdiagnosed. In summary, COVID-19 reinfections are possible and not exceptional.

摘要

SARS-CoV-2 再感染的报告正在增加。本研究关注的是捷克共和国确诊 COVID-19 患者的再感染情况。2020 年 3 月 1 日至 2020 年 11 月 9 日,报告了 362084 例发病前至 2020 年 10 月 31 日的病例。总体而言,确定了 28 例有症状的 SARS-CoV-2 再感染病例,男性 11 例,女性 17 例,年龄 25-80 岁,中位年龄 46 岁。两次疾病发作之间的间隔为 101-231 天,中位数间隔为 201.5 天。两次有症状的发作期间,所有患者均通过 RT-PCR 进行了检测。在首次感染 COVID-19 康复后,26 名患者(92.9%)的检测结果均为阴性。所有有风险的患者中,有近 0.2%的患者发生了症状性再感染。大多数再感染患者在两次发作中都有轻度症状,仅有三例为中度至重度。因此,再感染可能被漏诊了。总的来说,COVID-19 的再感染是可能的,而且并不罕见。

相似文献

1
COVID-19 reinfections.COVID-19 再感染。
Epidemiol Mikrobiol Imunol. 2021 Spring;70(1):62-67.
2
SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.SARS-CoV-2 再感染:巴西东南部两例报告。
Rev Inst Med Trop Sao Paulo. 2021 Jun 18;63:e50. doi: 10.1590/S1678-9946202163050. eCollection 2021.
3
SARS-CoV-2 reinfection and COVID-19 severity.SARS-CoV-2 再感染与 COVID-19 严重程度。
Emerg Microbes Infect. 2022 Dec;11(1):894-901. doi: 10.1080/22221751.2022.2052358.
4
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.从 COVID-19 第一波疫情中康复后,再次感染的风险较低,且与血清学反应有关。
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2597-2604. doi: 10.1007/s10096-021-04335-x. Epub 2021 Aug 11.
5
Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.2020 年 3 月至 2022 年 7 月塞尔维亚儿童和青少年中 SARS-CoV-2 再感染的发生率、风险和严重程度。
JAMA Netw Open. 2023 Feb 1;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779.
6
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染:医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
7
Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.尼加拉瓜儿童中 SARS-CoV-2 血清阳性与有症状再感染的相关性。
JAMA Netw Open. 2022 Jun 1;5(6):e2218794. doi: 10.1001/jamanetworkopen.2022.18794.
8
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.SARS-CoV-2 再感染可疑病例的发生率和严重程度在一组 PCR 阳性 COVID-19 患者中的研究。
Clin Microbiol Infect. 2021 Dec;27(12):1860.e7-1860.e10. doi: 10.1016/j.cmi.2021.07.030. Epub 2021 Aug 19.
9
Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.COVID-19 大流行期间医护人员 2 年以上的再感染率。
Sci Rep. 2023 Jan 13;13(1):712. doi: 10.1038/s41598-022-25908-6.
10
Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.西班牙早期涉及相同或不同基因组谱系的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2023 Jun;29(6):1154-1161. doi: 10.3201/eid2906.221696. Epub 2023 May 2.

引用本文的文献

1
Bayesian model selection for COVID-19 pandemic state estimation using extended Kalman filters: Case study for Saudi Arabia.使用扩展卡尔曼滤波器进行COVID-19大流行状态估计的贝叶斯模型选择:沙特阿拉伯的案例研究。
PLOS Glob Public Health. 2024 Jul 25;4(7):e0003467. doi: 10.1371/journal.pgph.0003467. eCollection 2024.
2
How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.免疫突破如何减缓 COVID-19 患者的疾病进展并改善预后:一项回顾性研究。
Front Immunol. 2023 Oct 23;14:1246751. doi: 10.3389/fimmu.2023.1246751. eCollection 2023.
3
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis.
全球 2019 冠状病毒病再感染的流行率:系统评价和荟萃分析。
BMC Public Health. 2023 Apr 28;23(1):778. doi: 10.1186/s12889-023-15626-7.
4
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
5
Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.抗体依赖性增强作用促进 SARS-CoV-2 感染的多种途径。
Microbiol Spectr. 2022 Apr 27;10(2):e0155321. doi: 10.1128/spectrum.01553-21. Epub 2022 Mar 23.
6
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.SARS-CoV-2 再感染:自然和混合免疫的疗效和持续时间概述。
Environ Res. 2022 Jun;209:112911. doi: 10.1016/j.envres.2022.112911. Epub 2022 Feb 8.
7
Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.韩国出现的新冠病毒二次感染的基因组证据。
J Med Virol. 2022 Apr;94(4):1717-1722. doi: 10.1002/jmv.27499. Epub 2021 Dec 9.
8
Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.系统基因组学和严重急性呼吸综合征冠状病毒 2 再感染和同一毒株复发的临床分析。
Emerg Infect Dis. 2022 Jan;28(1):85-94. doi: 10.3201/eid2801.211952. Epub 2021 Nov 29.
9
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战:对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.